DocuSign, Inc. (NASDAQ:DOCU) Receives Average Rating of “Hold” from Analysts

DocuSign, Inc. (NASDAQ:DOCU) has received a consensus rating of “Hold” from the thirteen analysts that are covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $92.45.

A number of research analysts recently commented on DOCU shares. Royal Bank of Canada reissued a “sector perform” rating and issued a $90.00 price target (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. Jefferies Financial Group upped their target price on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. JMP Securities reiterated a “market outperform” rating and issued a $124.00 price target on shares of DocuSign in a report on Tuesday, January 7th. Citigroup upped their price objective on DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a report on Friday, December 6th. Finally, UBS Group upped their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th.

Insider Buying and Selling

In related news, Director Peter Solvik sold 10,000 shares of the business’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares in the company, valued at $13,712,088.78. The trade was a 6.24 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $90.04, for a total value of $3,601,600.00. Following the completion of the sale, the chief executive officer now owns 156,050 shares in the company, valued at approximately $14,050,742. The trade was a 20.40 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 693,537 shares of company stock valued at $66,575,817. Company insiders own 1.66% of the company’s stock.

Institutional Investors Weigh In On DocuSign

Hedge funds have recently made changes to their positions in the company. J.W. Cole Advisors Inc. raised its stake in DocuSign by 2.0% in the third quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock worth $493,000 after buying an additional 155 shares in the last quarter. Resonant Capital Advisors LLC boosted its stake in DocuSign by 0.9% in the 3rd quarter. Resonant Capital Advisors LLC now owns 17,516 shares of the company’s stock worth $1,088,000 after purchasing an additional 157 shares in the last quarter. Optimist Retirement Group LLC grew its position in DocuSign by 3.8% during the 3rd quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock worth $274,000 after purchasing an additional 161 shares during the last quarter. V Square Quantitative Management LLC increased its stake in DocuSign by 6.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 3,019 shares of the company’s stock valued at $187,000 after purchasing an additional 172 shares in the last quarter. Finally, Covestor Ltd raised its holdings in shares of DocuSign by 5.8% in the third quarter. Covestor Ltd now owns 3,306 shares of the company’s stock worth $205,000 after buying an additional 182 shares during the last quarter. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

DocuSign Stock Up 0.1 %

Shares of DocuSign stock opened at $90.09 on Friday. The company has a market capitalization of $18.20 billion, a price-to-earnings ratio of 18.58, a PEG ratio of 8.70 and a beta of 0.88. The stock’s 50-day simple moving average is $87.95 and its 200-day simple moving average is $69.61. DocuSign has a 52 week low of $48.70 and a 52 week high of $107.86.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.